Chapter

Intranasal and intrapulmonary opioids

Andrew Davies

in Cancer-related Breakthrough Pain

Second edition

Published on behalf of Oxford University Press

Published in print August 2012 | ISBN: 9780199656974
Published online September 2012 | e-ISBN: 9780191740909 | DOI: http://dx.doi.org/10.1093/med/9780199656974.003.0007

Series: Oxford Pain Management Library

Intranasal and intrapulmonary opioids

More Like This

Show all results sharing these subjects:

  • Clinical Oncology
  • Clinical Pharmacology and Therapeutics
  • Pain Medicine

GO

Show Summary Details

Preview

• The suitability of different opioid delivery routes depends on a number of physicochemical and pharmaceutical factors • The intranasal route can be associated with rapid onset of analgesia, and intranasal fentanyl-based formulations are commercially available • The intrapulmonary route also has the potential for rapid onset of analgesia. Clinical studies are ongoing of fentanyl-based formulations.

Chapter.  2392 words.  Illustrated.

Subjects: Clinical Oncology ; Clinical Pharmacology and Therapeutics ; Pain Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.